 success strategi prevent cytomegaloviru interstiti pneumonia human leukocyt antigen-ident bone marrow transplant cytomegaloviru cmv interstiti pneumonia frequent fatal complic allogen bone marrow transplant therapi cmv pneumonia ineffect prophylact method studi strategi cmv seroneg blood product seroneg patient seroneg donor weekli administr intraven immunoglobulin patient attack rate cmv pneumonia result studi perspect data